PMID- 35133495
OWN - NLM
STAT- MEDLINE
DCOM- 20220303
LR  - 20220304
IS  - 1432-1963 (Electronic)
IS  - 0172-8113 (Print)
IS  - 0172-8113 (Linking)
VI  - 43
IP  - 2
DP  - 2022 Mar
TI  - [Diagnostic and predictive markers in urinary tract cytology].
PG  - 99-104
LID - 10.1007/s00292-022-01053-9 [doi]
AB  - Multiprobe fluorescence in situ hybridization (FISH) still remains the gold 
      standard for clarifying inconclusive atypia in urinary cytology in daily routine 
      practice. The Paris Classification System (The Paris System, TPS) provides an 
      important basis for the specific indication of FISH and emphasizes the importance 
      of morphological correlation for an integrative approach to diagnosis. 
      Next-generation sequencing technology in urinary specimens, which is highly 
      sensitive for simultaneous detection of multiple genetic alterations, is also 
      likely to play a diagnostic role in the near future.
CI  - (c) 2022. The Author(s).
FAU - Vlajnic, Tatjana
AU  - Vlajnic T
AD  - Pathologie, Institut fur medizinische Genetik und Pathologie, Universitatsspital 
      Basel, Schonbeinstr. 40, 4031, Basel, Schweiz. Tatjana.Vlajnic@usb.ch.
FAU - Bubendorf, Lukas
AU  - Bubendorf L
AD  - Pathologie, Institut fur medizinische Genetik und Pathologie, Universitatsspital 
      Basel, Schonbeinstr. 40, 4031, Basel, Schweiz.
LA  - ger
PT  - Journal Article
PT  - Review
TT  - Diagnostische und pradiktive Marker in der Harntraktzytologie.
DEP - 20220208
PL  - Germany
TA  - Pathologe
JT  - Der Pathologe
JID - 8006541
RN  - 0 (Biomarkers)
SB  - IM
MH  - Biomarkers
MH  - Cytodiagnosis
MH  - Humans
MH  - In Situ Hybridization, Fluorescence
MH  - *Urinary Tract/pathology
MH  - *Urologic Neoplasms/pathology
PMC - PMC8888376
OTO - NOTNLM
OT  - Differential diagnosis
OT  - High-throughput nucleotide sequencing
OT  - Immune checkpoint inhibitors
OT  - Immunohistochemistry
OT  - Urologic neoplasms
EDAT- 2022/02/09 06:00
MHDA- 2022/03/04 06:00
PMCR- 2022/02/08
CRDT- 2022/02/08 12:15
PHST- 2022/01/02 00:00 [accepted]
PHST- 2022/02/09 06:00 [pubmed]
PHST- 2022/03/04 06:00 [medline]
PHST- 2022/02/08 12:15 [entrez]
PHST- 2022/02/08 00:00 [pmc-release]
AID - 10.1007/s00292-022-01053-9 [pii]
AID - 1053 [pii]
AID - 10.1007/s00292-022-01053-9 [doi]
PST - ppublish
SO  - Pathologe. 2022 Mar;43(2):99-104. doi: 10.1007/s00292-022-01053-9. Epub 2022 Feb 
      8.